Author

Orges Ormanidhi

Observed institution: University of Toronto

OpenAlex ID: A5029587341

Porter’s model of generic competitive strategies

2008 · Orges Ormanidhi, Omer Stringa · RePEc: Research Papers in Economics · 75

Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients

2014 · Robert A. Fowler, Nicole Mittmann, et al. · JAMA · 60

Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial

2009 · Mark J. Sculpher, Greta Lozano-Ortega, et al. · American Heart Journal · 58

Porter's Model of Generic Competitive Strategies: An Insightful and Convenient Approach to Firms' Analysis

2008 · Orges Ormanidhi, Omer Stringa · Business Economics · 18

Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial

2014 · Robert A Fowler, Nicole Mittmann, et al. · Trials · 12

The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting – Can we do better?

2016 · Beate Sander, William W.L. Wong, et al. · Vaccine · 8

Works count: 8

Citation count: 231

H-index: 6

I10-index: 5